240 related articles for article (PubMed ID: 36691569)
1. CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma.
Romero-Cristóbal M; Clemente-Sánchez A; Ramón E; Téllez L; Canales E; Ortega-Lobete O; Velilla-Aparicio E; Catalina MV; Ibáñez-Samaniego L; Alonso S; Colón A; Matilla AM; Salcedo M; Albillos A; Bañares R; Rincón D
JHEP Rep; 2023 Mar; 5(3):100645. PubMed ID: 36691569
[TBL] [Abstract][Full Text] [Related]
2. Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma.
Souhami A; Sartoris R; Rautou PE; Cauchy F; Bouattour M; Durand F; Giannelli V; Gigante E; Castera L; Valla D; Soubrane O; Vilgrain V; Ronot M
JHEP Rep; 2020 Oct; 2(5):100147. PubMed ID: 32885156
[TBL] [Abstract][Full Text] [Related]
3. Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history.
Romero-Cristóbal M; Clemente-Sánchez A; Peligros MI; Ramón E; Matilla AM; Colón A; Alonso S; Catalina MV; Fernández-Yunquera A; Caballero A; García R; López-Baena JÁ; Salcedo MM; Bañares R; Rincón D
United European Gastroenterol J; 2022 Oct; 10(8):805-816. PubMed ID: 36065767
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive tests for clinically significant portal hypertension after HCV cure.
Semmler G; Lens S; Meyer EL; Baiges A; Alvardo-Tapias E; Llop E; Tellez L; Schwabl P; Mauro E; Escudé L; Díez C; Ibañez-Samaniego L; Puente Á; Fortea JI; Abadía M; Zanetto A; Conthe A; Hernandez-Évole H; Luzko Scheid IS; Jia J; Yoshiji H; Francque SM; Tsochatzis EA; Russo FP; Crespo G; Forns X; Bañares R; Villanueva C; Hernández-Gea V; Reiberger T; Bosch J; García Pagán JC; Mandorfer M;
J Hepatol; 2022 Dec; 77(6):1573-1585. PubMed ID: 36063968
[TBL] [Abstract][Full Text] [Related]
5. MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension.
Kennedy P; Stocker D; Carbonell G; Said D; Bane O; Hectors S; Abboud G; Cuevas J; Bolster BD; Friedman SL; Lewis S; Schiano T; Bhattacharya D; Fischman A; Thung S; Taouli B
Eur Radiol; 2022 Dec; 32(12):8339-8349. PubMed ID: 35727321
[TBL] [Abstract][Full Text] [Related]
6. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.
Berzigotti A; Seijo S; Arena U; Abraldes JG; Vizzutti F; García-Pagán JC; Pinzani M; Bosch J
Gastroenterology; 2013 Jan; 144(1):102-111.e1. PubMed ID: 23058320
[TBL] [Abstract][Full Text] [Related]
7. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient.
Jachs M; Hartl L; Simbrunner B; Semmler G; Balcar L; Hofer BS; Schwarz M; Bauer D; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M
J Hepatol; 2024 May; 80(5):744-752. PubMed ID: 38218352
[TBL] [Abstract][Full Text] [Related]
8. Accurate computed tomography-based portal pressure assessment in patients with hepatocellular carcinoma.
Iranmanesh P; Vazquez O; Terraz S; Majno P; Spahr L; Poncet A; Morel P; Mentha G; Toso C
J Hepatol; 2014 May; 60(5):969-74. PubMed ID: 24362073
[TBL] [Abstract][Full Text] [Related]
9. High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic-associated fatty liver disease.
Odriozola A; Puente Á; Cuadrado A; Iruzubieta P; Arias-Loste MT; Redondo C; Rivas C; Fábrega E; Crespo J; Fortea JI
Liver Int; 2023 Jul; 43(7):1446-1457. PubMed ID: 36912787
[TBL] [Abstract][Full Text] [Related]
10. Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort study.
Zykus R; Jonaitis L; Petrenkienė V; Pranculis A; Kupčinskas L
BMC Gastroenterol; 2015 Dec; 15():183. PubMed ID: 26702818
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Liver and Spleen Stiffness with Acoustic Radiation Force Impulse Quantification Elastography for Diagnosing Clinically Significant Portal Hypertension.
Attia D; Schoenemeier B; Rodt T; Negm AA; Lenzen H; Lankisch TO; Manns M; Gebel M; Potthoff A
Ultraschall Med; 2015 Dec; 36(6):603-10. PubMed ID: 26565516
[TBL] [Abstract][Full Text] [Related]
12. Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study.
Augustin S; Millán L; González A; Martell M; Gelabert A; Segarra A; Serres X; Esteban R; Genescà J
J Hepatol; 2014 Mar; 60(3):561-9. PubMed ID: 24211744
[TBL] [Abstract][Full Text] [Related]
13. Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis.
Reiniš J; Petrenko O; Simbrunner B; Hofer BS; Schepis F; Scoppettuolo M; Saltini D; Indulti F; Guasconi T; Albillos A; Téllez L; Villanueva C; Brujats A; Garcia-Pagan JC; Perez-Campuzano V; Hernández-Gea V; Rautou PE; Moga L; Vanwolleghem T; Kwanten WJ; Francque S; Trebicka J; Gu W; Ferstl PG; Gluud LL; Bendtsen F; Møller S; Kubicek S; Mandorfer M; Reiberger T
J Hepatol; 2023 Feb; 78(2):390-400. PubMed ID: 36152767
[TBL] [Abstract][Full Text] [Related]
14. Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension.
Azoulay D; Ramos E; Casellas-Robert M; Salloum C; Lladó L; Nadler R; Busquets J; Caula-Freixa C; Mils K; Lopez-Ben S; Figueras J; Lim C
JHEP Rep; 2021 Feb; 3(1):100190. PubMed ID: 33294830
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data.
Hong WK; Kim MY; Baik SK; Shin SY; Kim JM; Kang YS; Lim YL; Kim YJ; Cho YZ; Hwang HW; Lee JH; Chae MH; Kim HA; Kang HW; Kwon SO
Clin Mol Hepatol; 2013 Dec; 19(4):370-5. PubMed ID: 24459641
[TBL] [Abstract][Full Text] [Related]
16. Non-Invasive Diagnostic Tests for Portal Hypertension in Patients with HBV- and HCV-Related Cirrhosis: A Comprehensive Review.
Celsa C; Veneziano M; Di Giorgio FM; Cannova S; Lombardo A; Errigo E; Landro G; Simone F; Sinagra E; Calvaruso V
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792873
[TBL] [Abstract][Full Text] [Related]
17. Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India.
Kumar A; Khan NM; Anikhindi SA; Sharma P; Bansal N; Singla V; Arora A
World J Gastroenterol; 2017 Jan; 23(4):687-696. PubMed ID: 28216976
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors of clinically significant portal hypertension in patients with compensated liver cirrhosis based on hepatic venous pressure gradient].
Jiang FR; Yan HD
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):995-1000. PubMed ID: 34814395
[No Abstract] [Full Text] [Related]
19. The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.
Hametner S; Ferlitsch A; Ferlitsch M; Etschmaier A; Schöfl R; Ziachehabi A; Maieron A
PLoS One; 2016; 11(2):e0149230. PubMed ID: 26895398
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging.
Palaniyappan N; Cox E; Bradley C; Scott R; Austin A; O'Neill R; Ramjas G; Travis S; White H; Singh R; Thurley P; Guha IN; Francis S; Aithal GP
J Hepatol; 2016 Dec; 65(6):1131-1139. PubMed ID: 27475617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
